US Stock MarketDetailed Quotes
OTLK Outlook Therapeutics
- 2.030
- -0.020-0.98%
Close Dec 2 16:00 ET
- 2.100
- +0.070+3.45%
Post 20:01 ET
48.02MMarket Cap-344P/E (TTM)
2.420High1.980Low5.50MVolume2.070Open2.050Pre Close11.81MTurnover39.42%Turnover RatioLossP/E (Static)23.66MShares12.85052wk High-0.57P/B28.30MFloat Cap0.87052wk Low--Dividend TTM13.94MShs Float219.200Historical High--Div YieldTTM21.46%Amplitude0.870Historical Low2.148Avg Price1Lot Size
Outlook Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 7.83%19.56M | 176.98%18.94M | -34.20%10.32M | -15.77%53.13M | -10.93%12.46M | 6.56%18.14M | -63.84%6.84M | 19.30%15.69M | 21.93%63.07M | 4.11%13.99M |
| Selling and administrative expenses | 18.76%8.36M | -13.70%5.43M | -0.55%5.79M | 28.61%26.67M | 50.36%7.51M | 21.91%7.04M | -5.93%6.29M | 77.76%5.83M | 62.43%20.74M | 42.77%5M |
| -General and administrative expense | 18.76%8.36M | -13.70%5.43M | -0.55%5.79M | 28.61%26.67M | 50.36%7.51M | 21.91%7.04M | -5.93%6.29M | 77.76%5.83M | 62.43%20.74M | 42.77%5M |
| Research and development costs | 0.90%11.2M | 2,378.94%13.51M | -54.07%4.53M | -37.51%26.45M | -45.00%4.94M | -1.31%11.1M | -95.54%544.95K | -0.10%9.86M | 8.66%42.33M | -9.51%8.99M |
| Operating profit | -7.83%-19.56M | -176.98%-18.94M | 34.20%-10.32M | 15.77%-53.13M | 10.93%-12.46M | -6.56%-18.14M | 63.84%-6.84M | -19.30%-15.69M | -21.93%-63.07M | -4.11%-13.99M |
| Net non-operating interest income expense | 2.37%404.59K | -1,742.24%-3.08M | 107.71%188.68K | -4.86%-1.56M | 184.80%305.82K | 210.73%395.23K | 144.89%187.79K | -596.54%-2.45M | -58.89%-1.49M | -33.98%-360.65K |
| Non-operating interest income | 2.29%404.59K | ---- | ---- | ---- | ---- | --395.54K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | --0 | ---- | ---- | 4.86%1.56M | ---971.27K | --303 | ---- | ---- | 58.89%1.49M | ---- |
| Total other finance cost | ---- | 1,742.24%3.08M | -107.71%-188.68K | ---- | ---- | ---- | -144.89%-187.79K | --2.45M | ---- | ---- |
| Other net income (expense) | 2,270.32%63.57M | -6,834,132.07%-92.26M | -98.48%-1.04M | -187.93%-4.29M | -21,277.17%-837.56K | -1,741.47%-2.93M | 99.64%-1.35K | 45.31%-525.89K | -199.16%-1.49M | -98.68%3.96K |
| Gain on sale of security | 477,262.12%56.06M | -449,803.92%-83.71M | -276.28%-53.34K | -89.07%50.92K | 23.36%13.79K | -105.11%-11.75K | 174.42%18.62K | -87.89%30.26K | 203.02%465.78K | 112.61%11.18K |
| Earnings from equity interest | -699.90%-57.5K | -80.34%-30.6K | -88.15%2.55K | 77.43%-11K | -15.55%-8.35K | 39.11%-7.19K | -180.69%-16.97K | 190.91%21.51K | -5.16%-48.73K | -101.86%-7.23K |
| Special income (charges) | --0 | --0 | --0 | 43.67%-577.66K | --0 | --0 | --0 | 43.67%-577.66K | ---1.03M | --0 |
| -Less:Other special charges | ---- | ---- | ---- | -43.67%577.66K | --0 | ---- | ---- | -43.67%577.66K | --1.03M | --0 |
| Other non- operating income (expenses) | 359.90%7.56M | -283,871.77%-8.52M | ---993K | -325.41%-3.76M | ---843K | -671.96%-2.91M | 99.13%-3K | ---- | ---882.9K | --0 |
| Income before tax | 314.80%44.41M | -1,618.20%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.24%-6.65M | -29.04%-18.66M | -24.24%-66.05M | -7.01%-14.34M |
| Income tax | 0 | 0.00%2.8K | 0.00%2.8K | 0 | 0 | 40.00%2.8K | 40.00%2.8K | 800 | ||
| Net income | 314.80%44.41M | -1,617.52%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.23%-6.65M | -29.04%-18.66M | -24.24%-66.05M | -7.02%-14.35M |
| Net income continuous Operations | 314.80%44.41M | -1,617.52%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.23%-6.65M | -29.04%-18.66M | -24.24%-66.05M | -7.02%-14.35M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 314.80%44.41M | -1,617.52%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.23%-6.65M | -29.04%-18.66M | -24.24%-66.05M | -7.02%-14.35M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 66.96M | 0 | ||||||||
| Net income attributable to common stockholders | -9.05%-22.55M | -1,617.52%-114.29M | 40.10%-11.18M | 10.70%-58.98M | 9.44%-12.99M | -17.87%-20.68M | 66.23%-6.65M | -29.04%-18.66M | -24.24%-66.05M | -7.02%-14.35M |
| Basic earnings per share | 218.63%1.91 | -1,440.38%-8.01 | 50.00%-0.8 | 22.58%-4.8 | 10.83%-1.07 | -0.63%-1.61 | 71.11%-0.52 | 0.00%-1.6 | 11.43%-6.2 | 25.00%-1.2 |
| Diluted earnings per share | 44.72%-0.89 | -1,440.38%-8.01 | 50.00%-0.8 | 22.58%-4.8 | 10.83%-1.07 | -0.63%-1.61 | 71.11%-0.52 | 0.00%-1.6 | 11.43%-6.2 | 25.00%-1.2 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
